6.78 +0.63 (10.11%)
THRX
Stock Details
Last Trade:6.78 Change:+0.63 (10.11%) Prev Close:6.15 Open: 6.23 Days Range:6.23 – 6.84 52 Week Range: 4.32 - 26.09 Volume:1030046 P/E: N/AEPS:-1.81
View AllRecent Alerts 12/02/08
Recent Alert on 12/02/08 at 8:44am
Glaxo (GSK) and Theravance (THRX) Announce Positive Results from Phase 2b Study for LABA, '444
Glaxo (GSK) and Theravance (THRX) Announce Positive Results from Phase 2b Study for LABA, '444
GlaxoSmithKline Plc (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced positive results from the phase 2b study of the novel, long-acting beta agonist GW642444 ('444) in patients with moderate to severe asthma. The study, which was... Read More
Recent Alert on 11/17/08 at 9:47am
Theravance (THRX) Announces AIDAC Meeting to Review NDA for Telavancin
Theravance (THRX) Announces AIDAC Meeting to Review NDA for Telavancin
Recent Alert on 11/17/08 at 9:47am
Theravance (THRX) Announces AIDAC Meeting to Review NDA for Telavancin
Theravance (THRX) Announces AIDAC Meeting to Review NDA for Telavancin
View AllRecent Press Releases
Press Release on 12/02/08 at 8:00am
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Programme
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Programme